298 related articles for article (PubMed ID: 27973704)
1. Crosstalk between Hippo signalling and miRNAs in tumour progression.
Li N; Xie C; Lu N
FEBS J; 2017 Apr; 284(7):1045-1055. PubMed ID: 27973704
[TBL] [Abstract][Full Text] [Related]
2. Hippo signaling promotes JNK-dependent cell migration.
Ma X; Wang H; Ji J; Xu W; Sun Y; Li W; Zhang X; Chen J; Xue L
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1934-1939. PubMed ID: 28174264
[TBL] [Abstract][Full Text] [Related]
3. What is the Hippo pathway? Is the Hippo pathway conserved in Caenorhabditis elegans?
Yang Z; Hata Y
J Biochem; 2013 Sep; 154(3):207-9. PubMed ID: 23843471
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation.
Lin KC; Moroishi T; Meng Z; Jeong HS; Plouffe SW; Sekido Y; Han J; Park HW; Guan KL
Nat Cell Biol; 2017 Jul; 19(8):996-1002. PubMed ID: 28752853
[TBL] [Abstract][Full Text] [Related]
6. Disease implications of the Hippo/YAP pathway.
Plouffe SW; Hong AW; Guan KL
Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
[TBL] [Abstract][Full Text] [Related]
7. Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
Liu J; Li J; Li P; Wang Y; Liang Z; Jiang Y; Li J; Feng C; Wang R; Chen H; Zhou C; Zhang J; Yang J; Liu P
Sci Rep; 2017 Feb; 7():42125. PubMed ID: 28169360
[TBL] [Abstract][Full Text] [Related]
8. Mutual regulation between Hippo signaling and actin cytoskeleton.
Matsui Y; Lai ZC
Protein Cell; 2013 Dec; 4(12):904-10. PubMed ID: 24248471
[TBL] [Abstract][Full Text] [Related]
9. Targeting YAP and Hippo signaling pathway in liver cancer.
Liu AM; Xu MZ; Chen J; Poon RT; Luk JM
Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481
[TBL] [Abstract][Full Text] [Related]
10. A Hippo in the ointment: MST signalling beyond the fly.
Matallanas D; Romano D; Hamilton G; Kolch W; O'Neill E
Cell Cycle; 2008 Apr; 7(7):879-84. PubMed ID: 18414046
[TBL] [Abstract][Full Text] [Related]
11. The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.
Tu C; Yang K; Wan L; He J; Qi L; Wang W; Lu Q; Li Z
Cell Prolif; 2020 Sep; 53(9):e12887. PubMed ID: 32779318
[TBL] [Abstract][Full Text] [Related]
12. The Hippo pathway in intestinal regeneration and disease.
Hong AW; Meng Z; Guan KL
Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
[TBL] [Abstract][Full Text] [Related]
13. Silence of yki by miR-7 regulates the Hippo pathway.
Yu X; Li M; Cui M; Sun B; Zhou Z
Biochem Biophys Res Commun; 2020 Nov; 532(3):446-452. PubMed ID: 32888651
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
Hao Y; Chun A; Cheung K; Rashidi B; Yang X
J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
[TBL] [Abstract][Full Text] [Related]
15. Regulatory role of microRNAs in cancer through Hippo signaling pathway.
Astamal RV; Maghoul A; Taefehshokr S; Bagheri T; Mikaeili E; Derakhshani A; Delashoub M; Taefehshokr N; Isazadeh A; Hajazimian S; Tran A; Baradaran B
Pathol Res Pract; 2020 Dec; 216(12):153241. PubMed ID: 33065484
[TBL] [Abstract][Full Text] [Related]
16. YAP activates the Hippo pathway in a negative feedback loop.
Dai X; Liu H; Shen S; Guo X; Yan H; Ji X; Li L; Huang J; Feng XH; Zhao B
Cell Res; 2015 Oct; 25(10):1175-8. PubMed ID: 26315483
[No Abstract] [Full Text] [Related]
17. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
18. The dark side of hippo signaling: A cancer promoter role.
Dunn B; Ma X
Fly (Austin); 2017 Oct; 11(4):271-276. PubMed ID: 28574763
[TBL] [Abstract][Full Text] [Related]
19. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
[TBL] [Abstract][Full Text] [Related]
20. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
